Limei Ma

Dr. Limei Ma


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
PXPeng Xiang
Peng Xiang
QCQingqiu Chen
Qingqiu Chen
LCLe Chen
Le Chen
JLJin Lei
Jin Lei
ZYZhiyi Yuan
Zhiyi Yuan
LMLimei Ma
Limei Ma
Background: Atherosclerosis (AS) is still the major cause of cardiovascular disease (CVD) as well as stroke. Endothelial metabolic disorder has been found to be activated and then promote endothelial cells (ECs) injury, which is regarded to initiate AS progression. N-acetylneuraminic acid (Neu5Ac), a metabolite produced by hexosamine-sialic acid pathway branching from glucose metabolism, was presented as a notable biomarker of CVD and is positively correlated with ECs function. However, few studies explain whether Neu5Ac regulate AS progression by affecting EC function as well as its involved mechanisms are still unknown.

3 January 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JLJin Lei
Jin Lei
PXPeng Xiang
Peng Xiang
SZShengmei Zeng
Shengmei Zeng
LCLe Chen
Le Chen
LZLei Zhang
Lei Zhang
CYChao Yu
Chao Yu
Tetramethylpyrazine (TMP), a Chinese traditional herbal extraction widely used in treating cardiovascular diseases, could attenuate vascular endothelial injuries, but the underlying mechanism remains incomprehensive. Vascular glycocalyx coating on the endothelium would be damaged and caused endothelial dysfunction in the inflammatory microenvironment, which was the initial factor of morbidity of many vascular diseases, such as atherosclerosis (AS). Here, we thoroughly investigated the molecular mechanism of TMP on vascular endothelial glycocalyx in the LPS-induced inflammatory model both in vitro and in vivo. Results showed that pretreatment with TMP significantly inhibited glycocalyx degradation and monocytes adhesion to the endothelial process. Moreover, TMP pretreatment inhibited the expression of HPSE1 (a major degrading enzyme of endothelial glycocalyx), Toll-like receptor 4 (TLR4), and the translocation of nuclear factor kappa B p65 (NF-κB p65). We were utilized withTLR4 siRNA, NF-κB inhibitor, and HPSE1 overexpression analysis confirmed TMP’s protection on endothelial glycocalyx injury, which further contributed to the monocyte-endothelial adhesion process. It was indicated that TMP might suppress glycocalyx degradation through TLR4/NF-κB/HPSE1 signaling pathway. Taken together, our results enriched the occurrence molecular mechanism of glycocalyx shedding and molecular regulation mechanism of TMP in protecting integrity of the glycocalyx structure during inflammation. As TMP is currently used in clinical applications, it may be considered a novel strategy against atherosclerosis through its ability to protect endothelial glycocalyx.

13 November 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
ZLZhaohong Liu
Zhaohong Liu
PXPeng Xiang
Peng Xiang
SZShengmei Zeng
Shengmei Zeng
PWPing Weng
Ping Weng
YWYilin Wen
Yilin Wen
CYChao Yu
Chao Yu
Vascular endothelial injury initiates atherosclerosis (AS) progression. N-Acetylneuraminic acid (Neu5Ac) metabolic disorder was found to intensify endothelial mitochondrial damage. And GLS2-associated glutaminolysis disorder contributed to mitochondrial dysfunction. However, mechanisms underlying Neu5Ac-associated mitochondrial dysfunction as well as its association with GLS2 remains unclear. In this study, we constructed GLS2−/−ApoE−/− mice by using HBLV-GLS2 shRNA injection. And methods like immunofluorescence, western blotting, transmission electron microscopy were applied to detect profiles of endothelial injury and AS progression both in vivo and in vitro. We demonstrated that Neu5Ac accumulation increased GLS2 expression and promoted glutaminolysis disorder, which further induced endothelial mitochondrial dysfunction via a pyroptosis-dependent pathway in vivo and in vitro. Mechanically, Neu5Ac interacted with SIRT3 and led to FOXO3a deacetylation and phosphorylation, further facilitated c-Myc antagonism and ultimately increased GLS2 levels. Inhibition of GLS2 could improve mitochondrial function and mitigate pyroptosis process. In addition, blocking Neu5Ac production using neuraminidases (NEUs) inhibitor could rescue endothelial damage and alleviate AS development in ApoE−/− mice. These findings proposed that Neu5Ac induced GLS2-mediated glutaminolysis disorder and then promoted mitochondrial dysfunction in a pyroptosis-dependent pathway. Targeting GLS2 or inhibiting Neu5Ac production could prevent AS progression.

2 April 2020 in Xenobiotica
Verified
Journal Article
Closed access
HHHui He
Hui He
YZYuandong Zhang
Yuandong Zhang
DZDezhang Zhao
Dezhang Zhao
JJJunhao JIANG
Junhao JIANG
BXbaogang xie
baogang xie
CYChao Yu
Chao Yu
Osthol, a pharmacologically active ingredient in various traditional Chinese medicines, is predominantly metabolized by CYP2C9. It may be co-administered with other drugs which are metabolized by C...

14 July 2024 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
QCQingqiu Chen
Qingqiu Chen
RHRong Hu
Rong Hu
HQHongmei Qiu
Hongmei Qiu
SLShan Li
Shan Li
PXPeng Xiang
Peng Xiang
CYChao Yu
Chao Yu

30 June 2023 in Cellular Signalling
Verified
Journal Article
Closed access
LZLei Zhang
Lei Zhang
JLJiajia Li
Jiajia Li
JCJun Chen
Jun Chen
JLJin Lei
Jin Lei
ZYZhiyi Yuan
Zhiyi Yuan
LMLimei Ma
Limei Ma